Ethyl 8-benzyl-3-oxo-1-oxa-8-azaspiro[4.5]decane-4-carboxylate

Catalog No. :
ACCXGS652
CAS No. :
1454273-40-5
Molecular Formula :
C18H23NO4
Molecular Weight :
317.39

IUPAC Name:ethyl 8-benzyl-3-oxo-1-oxa-8-azaspiro[4.5]decane-4-carboxylate

Ethyl 8-benzyl-3-oxo-1-oxa-8-azaspiro[4.5]decane-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg93%$345.00Login to see priceIn stockInquiry
250mg93%$448.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 8-benzyl-3-oxo-1-oxa-8-azaspiro[4.5]decane-4-carboxylate
IUPAC Nameethyl 8-benzyl-3-oxo-1-oxa-8-azaspiro[4.5]decane-4-carboxylate
MDL No.MFCD29921896
Molecular FormulaC18H23NO4
Molecular Weight317.39
SMILESO=C(C1C(COC12CCN(CC3=CC=CC=C3)CC2)=O)OCC
InChI KeyBKDLLVICVUNNEG-UHFFFAOYSA-N
SynonymEthyl 8-Benzyl-3-Oxo-1-Oxa-8-Azaspiro[4.5]decane-4-Carboxylate;1-Oxa-8-azaspiro[4.5]decane-4-carboxylic acid, 3-oxo-8-(phenylmethyl)-, ethyl ester;8-Benzyl-3-oxo-1-oxa-8-azaspiro[4.5]decan-4-carboxylate
CAS No.1454273-40-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCXGS652 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJESB652 route compound structure diagram
    ACJESB6524727-72-4 In Stock
  4. Then
  5. ACCXGS652 route product structure diagram
    ACCXGS6521454273-40-5 In Stock
Inquiry

2. ACCXGS652 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCXGS652 route product structure diagram
    ACCXGS6521454273-40-5 In Stock
Inquiry

Comments (0)